Tag Archives: Thomas McLain

Exosome Diagnostics, a leading developer of non-invasive, biofluid-based molecular diagnostics, today announced the appointment of Thomas McLain as its chief executive officer, effective July 23, 2014. The company is also announcing the relocation of its headquarters to Cambridge, Mass. “I ...

Read More »